Back to Search
Start Over
Supplementary Legend from Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Legend
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....c673b41d7e1809c121882b30b75a551f
- Full Text :
- https://doi.org/10.1158/1078-0432.22481000